1Bone RC. Sir Isaac Newton, sepsis, SIRS, and CARS. Crit Care Med,1996, 24:1125-1128.
2Ostanin AA, Leplina OY, Shevela CY, et al. Inflammatory Syndromes (SIRS, MARS, CARS ) in Patients with Surgical Infection. Russ J Immunol,2000,5:289-300.
3Kluth DC, Rees Aj. Inhibiting inflammatory cytokines. Semin Neohrol. 1996.16,576-582.
4DiPiro JT. Cytokine networks with infection : mycobacterial infections, leishmaniasis, human immunodeficiency virus infection,and sepsis. Pharmacotherapy, 1997,17:205-223.
5Esmon CT. Introduction: are natural anticoagulants candidates for modulating the inflammatory response to endotoxin? Blood , 2000,95:1113-1116.
6Yoshinari D, Takeyoshi I, Koibuchi Y, et al. Effects of a dual inhibitor of tumor necrosis factor-alpha and interleukin-1 on lipopolysaccharide-induced lung injury in rats: involvement of the p38 mitogen-activated protein kinase pathway. Crit Care Med. 2001,29:628-634.
7Bocharov AV, Baranova IN, Vishnyakova TG, et al. Targeting of scavenger receptor class B type I by synthetic amphipathic alphahelical-containing peptides blocks lipopolysaccharide (LPS) uptake and LPS-induced pro-inflammatory cytokine responses in THP-1 monocyte cells. J Biol Chem ,2004,279 : 36072-36082.
8Lien E, Sellati TJ, Yoshimum A,et al. Toll-like receptor 2 functions as a pattern recognition receptor for diverse bacterial products. J Biol Chem, 1999, 274 : 33419-33425.
9Takeuchi O, Hoshino K, Kawai T, et aL Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity, 1999,11:443-451.
10Barber RC, Aragaki CC, Rivera-Chavez FA, et al. TLR4 and TNF-alpha polymorphisms are associated with an increased risk for severese psis following bum injury. J Med Genet,2004,41:808-813.
二级参考文献14
1Stuber F. Effects of genomic polymorphisms on the course of sepsis: is there a concept for gene therapy? J Am Soc Nephrol, 2001, 12:60-64.
2Koch W, Kastrati A, Bottiger C, et al. Interleukin-10 and tumor necrosis factor gene polymorphisms and risk of coronary artery disease and myocardial infarction. Atherosclerosis, 2001, 159:137-144.
3Skoog T, van′t Hooft FM, Kallin B, et al. A common functional polymorphism (C/A substitution at position -863) in the promoter region of the tumor necrosis factor alpha gene associated with reduced circulating levels TNF-α. Hum Mol Genet, 1999, 8:1443-1449.
4Gibot S, Cariou A, Drouet L, et al. Association between a genomic polymorphism within the CD14 locus and septic shock susceptibility and mortality rate. Crit Care Med, 2002, 30:969-973.
5Tarkowski E, Liljeroth AM, Nilsson A, et al. TNF gene polymorphism and its relation to intracerebral production of TNF-α and TNF-β in AD. Neurology,2000, 54: 1-11.
6Sun KH, Yu CL, Tang SJ,et al. Monoclonal anti-double-stranded DNA autoantibody stimulates the expression and release of IL-1, IL-6, IL-8, IL-10 and TNF alpha from normal human mononuclear cells involving in the lupus pathogenesis. Immunology, 2000, 99: 352-360.
7Hajeer AH, Hutchinson IV. Influence of TNF alpha gene polymorphisms on TNF alpha production and disease. Hum Immunol, 2001,69:1191-1199.
8Zhang DL, Li JS, Jiang ZW, et al. The associations of polymorphisms of tumor necrosis factor gene with acute severe pancreatitis. J Chin Med, 2002,82: 1529-1531.
9Mira JP, Cariou A, Grall F, et al. Association of TNF2, a TNF-alpha promoter polymorphism, with septic shock susceptibility and mortality: a multicenter study. JMMA, 1998, 28: 561-568.
10Majetschak M, Flohe S, Obertacke U, et al. Relation of a TNF gene polymorphism to severe sepsis in trauma patients. Ann Surg,1999, 230: 207-213.
